Quantum BioPharma Ltd.

US$2.10As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:QNTMHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (55.08%)
Div yield —
ROE (621.46%)
Biotechnology
Beta (5Y) 0.48
PE TTM —
TSR TTM (80.98%)
Mkt cap US$17.83M
ROIC (135.35%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.46
16.97%
(55.11%)
Hold 0|4|6|12|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.03
0.03
12.19%
4.02%
9.04%
5.88%
Revenue$M
1.684
1.695
1.723
1.772
(1.56%)
0.29%
3.86%
5.11%
Peers (US$17.83M)
Cap (US$)
PE
18.28M
—
Capital
TTM
5Y
10Y
Leveragex
0.233
(0.038)
(0.037)
EBIT/Intx
2.936
0.181
0.175
Own earn%
(57.47)
57.59
61.40
Sh yield%
41.95
23.68
22.40
Owners
Insiders/Inst%
14.96
56.20
Short interest%
4.46
SBC / revenue%
3.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
6–13
$1 testx
−0.2
Incr. ROIC%
72